S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
UNH · UNITEDHEALTH GROUP INCORPORATED (Delaware)
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
UnitedHealth Group Inc (UNH)
NEW YORK STOCK EXCHANGE, INC.
Health Care
$416.86
-2.61
(-0.62%)
● At close: October 21 at 4:00:00 PM EDT
$416.59
-0.41
(-0.10%)
After-Hours:
6:58:20 PM EDT
DAY'S RANGE
$416.86
$415.08
$421.35
52-WEEK RANGE
$416.86
$255.97
$461.62
What's happening
- UNH is down 0.62% today, trading at $416.86. — Live quote
- Volume today (242,017) is well below its 3-month average of 5,488,270. (Finnhub fundamentals)
- Last quarter's EPS beat estimates: $4.69 actual vs. $4.18 estimated (+12.2%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 8
Buy 18
Hold 7
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (33 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
UNH
+27.01%
vs S&P 500
+14.23%
1-YEAR RETURN
UNH
+15.03%
vs S&P 500
+0.47%
6-MONTH RETURN
UNH
+32.51%
3-MONTH RETURN
UNH
-3.92%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-10-13 (Q3 2026)
$4.69
Est. $4.18
BEAT +12.2%
2026-07-26 (Q2 2026)
$6.38
Est. $4.95
BEAT +28.8%
2026-04-26 (Q1 2026)
$7.23
Est. $6.64
BEAT +8.9%
2026-01-26 (Q4 2025)
$2.11
Est. $2.12
MISS -0.6%
Valuation Measures & Ratios
Enterprise Value4$423.20B
Forward P/E517.09
PEG Ratio61.48
Price / Sales (TTM1)0.84
Price / Book73.16
EV4 / Revenue0.94
EV4 / EBITDA15.20
Profit Margin3.53%
Operating Margin5.25%
Return on Equity (ROE8)16.10%
Return on Assets (ROA9)5.10%
Avg Volume (3M)5,488,270
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $374.87B | $243.34B | $304.99B | $274.90B | $462.05B |
| P/E | 21.40 | 13.28 | 16.85 | 13.77 | 30.49 |
| Price/Sales | 0.84 | 0.55 | 0.70 | 0.65 | 1.13 |
| EV/Revenue | 0.93 | 0.64 | 0.80 | 0.76 | 1.23 |
| ROA | 5.66% | 5.86% | 5.74% | 6.47% | 4.89% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short15,950,438
Change from Prior Settlement+20.69%
% of Float—
Days to Cover (Short Ratio)3.28
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +15.0%. Finnhub market metrics ↗
- Latest SEC filing is Form 8-K, filed 2026-10-13; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -0.4% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 3.5%. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on UNH
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $112.03B | $111.72B | $113.16B | $111.62B | $109.58B | $100.82B | $98.86B | $99.80B |
| Operating income | $7.99B | $8.99B | $4.32B | $5.15B | $9.12B | $8.71B | $7.88B | $7.93B |
| Net income | $5.48B | $6.28B | $2.35B | $3.41B | $6.29B | $6.05B | $4.22B | -$1.41B |
| EPS (diluted) | $6.04 | $6.90 | $2.59 | $3.74 | $6.85 | $6.51 | $4.54 | $-1.53 |
| EPS (basic) | $6.06 | $6.92 | $2.59 | $3.76 | $6.90 | $6.56 | $4.58 | $-1.53 |
| Operating margin | $7 | $8 | $4 | $5 | $8 | $9 | $8 | $8 |
| Net margin | $5 | $6 | $2 | $3 | $6 | $6 | $4 | -$1 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B |
| Total liabilities | $203.78B | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B | $195.69B | $194.85B |
| Stockholders' equity | — | — | — | — | — | — | — | — |
| Total current assets | $86.86B | $91.13B | $90.58B | $95.07B | $93.70B | $96.28B | $85.78B | $92.26B |
| Total current liabilities | $111.82B | $114.12B | $114.90B | $115.53B | $110.78B | $113.47B | $103.77B | $101.56B |
| Cash & equivalents | $28.59B | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | $25.31B | $32.40B |
| Marketable securities (current) | $2.88B | $3.23B | $3.76B | $3.40B | $3.42B | $3.57B | $3.80B | $4.73B |
| Accounts receivable | $21.57B | $26.59B | $23.02B | $22.67B | $24.14B | $26.94B | $22.36B | $20.02B |
| Inventory | — | — | $3.30B | — | — | — | $3.80B | — |
| Other current assets | — | — | — | — | — | — | — | — |
| Marketable securities (non-current) | $57.72B | $56.79B | $54.25B | $53.00B | $52.47B | $51.86B | $52.35B | $48.69B |
| Property, plant & equipment | $10.76B | $10.67B | $10.76B | $11.10B | $10.92B | $10.73B | $10.55B | $10.14B |
| Goodwill | $110.64B | $110.51B | $110.50B | $110.34B | $107.68B | $107.57B | $106.73B | $105.98B |
| Intangible assets | $19.75B | $20.09B | $20.47B | $22.79B | $22.51B | $22.95B | $23.27B | $23.59B |
| Other non-current assets | $24.00B | $23.46B | $23.01B | $22.98B | $21.30B | $20.39B | $19.59B | $18.65B |
| Deferred revenue (current) | $2.99B | $3.42B | $3.41B | $3.37B | $3.03B | $3.30B | $3.32B | $3.32B |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | $26.34B | $25.94B | $28.05B | $28.21B | $29.29B | $29.49B | $27.35B | $27.30B |
| Long-term debt | $69.50B | $71.44B | $72.32B | $72.40B | $73.50B | $71.28B | $72.36B | $74.10B |
| Other non-current liabilities | $19.73B | $18.90B | $18.25B | $18.37B | $15.71B | $15.96B | $15.94B | $15.17B |
| Common stock & paid-in capital | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M |
| Retained earnings | $100.96B | $99.88B | $95.60B | $97.59B | $97.25B | $97.93B | $96.04B | $96.52B |
| Accumulated other comprehensive income (loss) | -$2.52B | -$2.56B | -$2.06B | -$2.21B | -$2.54B | -$2.90B | -$3.39B | -$2.45B |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $11.05B | $8.91B | $1.11B | $5.95B | $7.19B | $5.46B | $2.37B | $13.95B |
| Investing cash flow | -$1.80B | -$2.45B | -$2.61B | -$4.56B | -$1.44B | -$74.0M | -$1.12B | -$5.65B |
| Financing cash flow | -$8.62B | -$2.99B | -$1.03B | -$2.77B | -$7.95B | $99.0M | -$8.34B | -$2.21B |
| Free cash flow | $10.25B | $8.15B | $160.0M | $5.05B | $6.30B | $4.56B | $1.46B | $12.95B |
| Capital expenditures | $799.0M | $763.0M | $948.0M | $890.0M | $886.0M | $898.0M | $912.0M | $991.0M |
| Share-based compensation | $276.0M | $348.0M | $176.0M | $223.0M | $197.0M | $375.0M | $187.0M | $237.0M |
| Deferred income taxes | -$129.0M | $540.0M | -$733.0M | -$932.0M | -$151.0M | $64.0M | -$62.0M | $124.0M |
| Change in accounts receivable | -$5.03B | $3.54B | $829.0M | -$1.75B | -$2.78B | $4.46B | $2.12B | -$3.16B |
| Purchases of investments | $3.61B | $6.51B | $4.57B | $4.62B | $4.04B | $4.13B | $7.36B | $9.82B |
| Sales/maturities of investments | $786.0M | $1.88B | $1.34B | $2.76B | $2.00B | $3.19B | $3.45B | $9.78B |
| Other investing activities | -$178.0M | -$21.0M | -$1.82B | $2.07B | $66.0M | $24.0M | -$1.19B | -$129.0M |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | $1.65B | $0 | $0 | $0 | $2.54B | $3.00B | $4.97B | $956.0M |
| Debt issued | $0 | — | $0 | $0 | $2.97B | $0 | $0 | $11.89B |
| Debt repaid | $1.00B | $1.50B | $1.05B | $2.00B | $0 | $0 | $500.0M | $750.0M |
| Other financing activities | -$337.0M | -$1.42B | $666.0M | -$90.0M | -$8.0M | -$505.0M | -$432.0M | -$460.0M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B |
| Operating income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B |
| Net income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B |
| EPS (diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 |
| EPS (basic) | $13.28 | $15.64 | $24.12 | $21.47 | $18.33 |
| Operating margin | $4 | $8 | $9 | $9 | $8 |
| Net margin | $3 | $4 | $6 | $6 | $6 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B |
| Total liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B |
| Stockholders' equity | — | — | — | — | — |
| Total current assets | $90.58B | $85.78B | $78.44B | $69.07B | $61.76B |
| Total current liabilities | $114.90B | $103.77B | $99.05B | $89.24B | $78.29B |
| Cash & equivalents | $24.36B | $25.31B | $25.43B | $23.36B | $21.38B |
| Marketable securities (current) | $3.76B | $3.80B | $4.20B | $4.55B | $2.53B |
| Accounts receivable | $23.02B | $22.36B | $21.28B | $17.68B | $14.22B |
| Inventory | $3.30B | $3.80B | $2.80B | $3.50B | $2.90B |
| Marketable securities (non-current) | $54.25B | $52.35B | $47.61B | $43.73B | $43.11B |
| Property, plant & equipment | $10.76B | $10.55B | $11.45B | $10.13B | $8.97B |
| Goodwill | $110.50B | $106.73B | $103.73B | $93.35B | $75.80B |
| Intangible assets | $20.47B | $23.27B | $15.19B | $14.40B | $10.04B |
| Other non-current assets | $23.01B | $19.59B | $17.30B | $15.03B | $12.53B |
| Deferred revenue (current) | $3.41B | $3.32B | $3.35B | $3.08B | $2.57B |
| Other current liabilities | $28.05B | $27.35B | $27.07B | $26.28B | $22.98B |
| Long-term debt | $72.32B | $72.36B | $58.26B | $54.51B | $42.38B |
| Other non-current liabilities | $18.25B | $15.94B | $14.46B | $12.84B | $11.79B |
| Common stock & paid-in capital | $9.0M | $9.0M | $9.0M | $9.0M | $10.0M |
| Retained earnings | $95.60B | $96.04B | $95.77B | $86.16B | $77.13B |
| Accumulated other comprehensive income (loss) | -$2.06B | -$3.39B | -$7.03B | -$8.39B | -$5.38B |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $19.70B | $24.20B | $29.07B | $26.21B | $22.34B |
| Investing cash flow | -$8.69B | -$20.53B | -$15.57B | -$28.48B | -$10.37B |
| Financing cash flow | -$11.64B | -$3.51B | -$11.53B | $4.23B | -$7.46B |
| Free cash flow | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B |
| Capital expenditures | $3.62B | $3.50B | $3.39B | $2.80B | $2.45B |
| Share-based compensation | $971.0M | $1.02B | $1.06B | $925.0M | $800.0M |
| Deferred income taxes | -$1.75B | -$296.0M | -$245.0M | -$673.0M | $130.0M |
| Change in accounts receivable | $764.0M | $1.44B | $3.11B | $2.52B | $1.00B |
| Purchases of investments | $17.37B | $27.31B | $18.31B | $18.82B | $17.14B |
| Sales/maturities of investments | $9.29B | $18.51B | $7.31B | $5.91B | $7.04B |
| Other investing activities | $341.0M | $98.0M | -$91.0M | $793.0M | $1.27B |
| Dividends paid | — | — | — | — | — |
| Share repurchases | $5.54B | $9.00B | $8.00B | $7.00B | $5.00B |
| Debt issued | $2.97B | $17.81B | $6.39B | $14.82B | $6.93B |
| Debt repaid | $3.05B | $3.00B | $2.12B | $3.02B | $3.15B |
| Other financing activities | $63.0M | -$1.65B | -$1.15B | -$1.94B | -$295.0M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding UNH as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers60.0%
Shares Outstanding902,000,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 76,863,061 | $31.95B | 8.52% | +4.6% | 2026-08-07 |
| VANGUARD CAPITAL MANAGEMENT LLC | 59,311,525 | $24.65B | 6.58% | +0.7% | 2026-06-30 |
| State Street Corp | 45,633,267 | $18.97B | 5.06% | +0.7% | 2026-08-07 |
| Capital World Investors | 29,887,932 | $12.42B | 3.31% | +7.6% | 2026-08-07 |
| FMR LLC | 27,992,995 | $11.63B | 3.10% | +132.9% | 2026-08-13 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 24,483,234 | $10.18B | 2.71% | +1.9% | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 23,153,813 | $9.6M | 2.57% | +10.9% | 2026-08-14 |
| GEODE CAPITAL MANAGEMENT, LLC | 21,751,937 | $9.01B | 2.41% | -4.5% | 2026-08-12 |
| Jpmorgan Chase & Co | 20,246,047 | $8.50B | 2.24% | +6.0% | 2026-08-12 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 19,830,588 | $8.24B | 2.20% | -4.7% | 2026-08-14 |
| Sixth Street Partners Management Company, L.P. | 19,830,588 | $8.24B | 2.20% | +0.0% | 2026-08-13 |
| Morgan Stanley | 14,795,456 | $6.15B | 1.64% | -1.1% | 2026-08-11 |
| NORGES BANK | 12,736,973 | $5.29B | 1.41% | +0.0% | 2026-08-12 |
| Bank of New York Mellon Corp | 10,704,994 | $4.45B | 1.19% | +6.1% | 2026-08-06 |
| WELLINGTON MANAGEMENT GROUP LLP | 10,675,175 | $4.44B | 1.18% | +5.8% | 2026-08-14 |
| Capital Research Global Investors | 10,534,177 | $4.38B | 1.17% | -38.4% | 2026-08-07 |
| Bank Of America Corp /De/ | 9,735,874 | $4.05B | 1.08% | -16.9% | 2026-08-14 |
| Fisher Asset Management, LLC | 9,082,269 | $3.77B | 1.01% | +73.4% | 2026-08-04 |
| DODGE & COX | 9,072,258 | $3.77B | 1.01% | -4.2% | 2026-08-13 |
| Northern Trust Corp | 8,761,055 | $3.64B | 0.97% | -0.2% | 2026-08-12 |
| Franklin Templeton Inc | 8,643,789 | $3.59B | 0.96% | +52.3% | 2026-08-04 |
| Corient Private Wealth LP | 8,451,751 | $245.5M | 0.94% | +1444.5% | 2026-08-12 |
| Capital International Investors | 7,789,028 | $3.24B | 0.86% | -13.5% | 2026-08-07 |
| ALLIANCEBERNSTEIN L.P. | 7,669,420 | $2.08B | 0.85% | +19.0% | 2026-08-14 |
| Goldman Sachs Group Inc | 6,974,132 | $2.90B | 0.77% | -11.0% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-08-21 to 2026-10-01
Recent transactions
- Insiders have net sold 1,169 shares over the last 182 days, across 0 purchases and 1 sale.
- Most recent: Noseworthy John H (Director) — Grant / award of 240 shares on 2026-10-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)1,169 sh(1 txns)
Net Shares-1,169
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Noseworthy John H | Director | Grant / award | 2026-10-01 | 240 |
| MONTGOMERY RICE VALERIE MD | Director | Grant / award | 2026-10-01 | 257 |
| MCNABB FREDERICK WILLIAM III | Director | Grant / award | 2026-10-01 | 291 |
| Gottlieb Scott | Director | Grant / award | 2026-10-01 | 257 |
| Gil Kristen | Director | Grant / award | 2026-10-01 | 240 |
| GARCIA PAUL R | Director | Grant / award | 2026-10-01 | 155 |
| FLYNN TIMOTHY PATRICK | Director | Grant / award | 2026-10-01 | 262 |
| Baker Charles D. | Director | Grant / award | 2026-10-01 | 257 |
| Stankiewicz Dennis Andrew | Chief Accounting Officer | Grant / award | 2026-09-22 | 51 |
| Zaetta Christopher R | EVP & Chief Legal Officer | Grant / award | 2026-09-22 | 67 |
| HEMSLEY STEPHEN J | CEO, UHG | Grant / award | 2026-09-22 | 50 |
| Conway Patrick Hugh | Chief Executive Officer, Optum | Grant / award | 2026-09-22 | 91 |
| DeVeydt Wayne S | Chief Financial Officer | Grant / award | 2026-09-22 | 106 |
| Noel Timothy John | Chief Executive Officer, UHC | Grant / award | 2026-09-22 | 84 |
| McSweeney Erin | EVP & Chief People Officer | Grant / award | 2026-09-22 | 53 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | Noseworthy John H | Director | Grant / award | 240 | $0.00 |
| 2026-10-01 | MONTGOMERY RICE VALERIE MD | Director | Grant / award | 257 | $0.00 |
| 2026-10-01 | MCNABB FREDERICK WILLIAM III | Director | Grant / award | 291 | $0.00 |
| 2026-10-01 | Gottlieb Scott | Director | Grant / award | 257 | $0.00 |
| 2026-10-01 | Gil Kristen | Director | Grant / award | 240 | $0.00 |
| 2026-10-01 | GARCIA PAUL R | Director | Grant / award | 155 | $0.00 |
| 2026-10-01 | GARCIA PAUL R | Director | Grant / award | 103 | $0.00 |
| 2026-10-01 | FLYNN TIMOTHY PATRICK | Director | Grant / award | 262 | $0.00 |
| 2026-10-01 | Baker Charles D. | Director | Grant / award | 257 | $0.00 |
| 2026-09-22 | MCNABB FREDERICK WILLIAM III | Director | Grant / award | 57 | $0.00 |
| 2026-09-22 | Stankiewicz Dennis Andrew | Chief Accounting Officer | Grant / award | 51 | $0.00 |
| 2026-09-22 | Baker Charles D. | Director | Grant / award | 15 | $0.00 |
| 2026-09-22 | FLYNN TIMOTHY PATRICK | Director | Grant / award | 68 | $0.00 |
| 2026-09-22 | Noseworthy John H | Director | Grant / award | 46 | $0.00 |
| 2026-09-22 | Gottlieb Scott | Director | Grant / award | 5 | $0.00 |
| 2026-09-22 | Zaetta Christopher R | EVP & Chief Legal Officer | Grant / award | 67 | $0.00 |
| 2026-09-22 | HEMSLEY STEPHEN J | CEO, UHG | Grant / award | 50 | $0.00 |
| 2026-09-22 | MONTGOMERY RICE VALERIE MD | Director | Grant / award | 47 | $0.00 |
| 2026-09-22 | GARCIA PAUL R | Director | Grant / award | 16 | $0.00 |
| 2026-09-22 | Gil Kristen | Director | Grant / award | 10 | $0.00 |
| 2026-09-22 | Conway Patrick Hugh | Chief Executive Officer, Optum | Grant / award | 91 | $0.00 |
| 2026-09-22 | DeVeydt Wayne S | Chief Financial Officer | Grant / award | 106 | $0.00 |
| 2026-09-22 | Noel Timothy John | Chief Executive Officer, UHC | Grant / award | 84 | $0.00 |
| 2026-09-22 | McSweeney Erin | EVP & Chief People Officer | Grant / award | 53 | $0.00 |
| 2026-09-02 | DeVeydt Wayne S | Chief Financial Officer | Tax withholding | 1,209 | $399.66 |
| 2026-08-21 | Conway Patrick Hugh | Chief Executive Officer, Optum | Open market sale | 1,169 | $390.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:14 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-13 | 8-K | 2026-10-13 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-09-24 | 4 | 2026-09-22 | View on SEC.gov → |
| 2026-09-24 | 4 | 2026-09-22 | View on SEC.gov → |
| 2026-09-24 | 4 | 2026-09-22 | View on SEC.gov → |
Recent news
Headlines about UNH (UNITEDHEALTH GROUP INCORPORATED (Delaware)). Links open the publisher — we don’t host full articles.
-
UNH Oct 2026 330.000 call (UNH261030C00330000) interactive stock chart
Yahoo Finance Australia · 2026-10-21 -
Sector Update: Healthcare Stocks Softer Late Afternoon
Yahoo · 2026-10-21 -
Microsoft and Alphabet opt out of tokenized stocks in latest blow to ambitious plan from OKK and NYSE parent firm
Yahoo · 2026-10-21 -
Microsoft and Alphabet opt out of tokenized stocks in latest blow to ambitious plan from OKX and NYSE parent firm
Yahoo Finance · 2026-10-21 -
What Elevance Health (ELV) Said on Its Q3 Earnings Call
Yahoo · 2026-10-21 -
UnitedHealth (UNH): Does Optum Truly Diversify Its Earnings Risk?
Yahoo · 2026-10-21 -
What Could Stop CVS Health Stock Over The Next Six Months?
Yahoo · 2026-10-21 -
Forget Stock Picking: The $100B Dividend ETF Retirees Are Buying Instead
Yahoo · 2026-10-21
No headlines in this category right now — try “All”.